2007
DOI: 10.1002/ar.20552
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Prolactin and Bromocriptine on the Population of Prostate Neuroendocrine Cells from Intact and Cyproterone Acetate‐Treated Rats: Stereological and Immunohistochemical Study

Abstract: This work deals with the quantification of serotonin-immunoreactive prostate neuroendocrine cells (NECs) in rats exposed to prolactin in normal, cyproterone acetate-exposed, and bromocriptine-exposed animals to establish the possible influence of prolactin with or without androgenic blockade on this cell population. Thirty male peripubertal Sprague-Dawley rats were grouped as controls (CT) and those treated with cyproterone acetate (CA), cyproterone acetate plus prolactin, cyproterone acetate plus bromocriptin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 52 publications
0
4
0
Order By: Relevance
“…The effect of CA may not be solely attributable to the androgen blockade, because CA also exerts antigonadotropic action (Raudrant and Rabe, 2003) and even a possible hyperprolactinemic action (Fonzo et al, 1977). These responses of the epithelial population of rat prostate to androgenic blockade and PL treatment, were, in part, different from those observed for other lineages of cells from peripubertal prostate epithelium, as, for instance, the amount of neuroendocrine cells decreases after androgenic blockade but increases with treatment with PL (Ingelmo et al, 2007). Fig.…”
Section: Discussionmentioning
confidence: 82%
“…The effect of CA may not be solely attributable to the androgen blockade, because CA also exerts antigonadotropic action (Raudrant and Rabe, 2003) and even a possible hyperprolactinemic action (Fonzo et al, 1977). These responses of the epithelial population of rat prostate to androgenic blockade and PL treatment, were, in part, different from those observed for other lineages of cells from peripubertal prostate epithelium, as, for instance, the amount of neuroendocrine cells decreases after androgenic blockade but increases with treatment with PL (Ingelmo et al, 2007). Fig.…”
Section: Discussionmentioning
confidence: 82%
“…NE cells in the PZ are unlikely to affect the development of BPH. In previous studies, the investigators often counted the NE cells as a proportion of total epithelial cells [ 12 , 18 , 19 ] but we evaluated them by the density in all cells in the TZ because we considered that NE cells had an effect on not only epithelial cells but also stromal cells in a paracrine fashion [ 17 ]. This is the first attempt to do so.…”
Section: Discussionmentioning
confidence: 99%
“…CD24 is a potential oncogene reported to be overexpressed in a large variety of human malignancies. 31 We selected the prolactin receptor for further characterization, as this polypeptide growth factor-receptor axis has been implicated in the development of the normal, 32,33 hyperplastic, 34 and neoplastic 35 prostate. We found the prolactin receptor to be overexpressed in ductal versus acinar adenocarcinoma at both the transcript level and at the protein level, as validated by immunohistochemistry.…”
Section: Discussionmentioning
confidence: 99%
“…We found the prolactin receptor to be overexpressed in ductal versus acinar adenocarcinoma at both the transcript level and at the protein level, as validated by immunohistochemistry. Whether the prolactin receptor might affect ductal adenocarcinoma growth to a greater degree than acinar adenocarcinoma is not known, but it is of interest that prolactin promotes ductal morphogenesis 34 and an increase in volume of ductal epithelium 32 in rodent prostates. It should be noted that the prolactin receptor, although overexpressed in ductal compared with acinar adenocarcinoma, does not seem to be practical marker in immunohistochemistry for ductal adenocarcinoma, because of the overlap in immunopositivity in ductal and acinar adenocarcinomas.…”
Section: Discussionmentioning
confidence: 99%